These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 3119551)

  • 21. Phenotypic and molecular antibiotic resistance profile of Enterococcus faecalis and Enterococcus faecium isolated from different traditional fermented foods.
    Sánchez Valenzuela A; Lavilla Lerma L; Benomar N; Gálvez A; Pérez Pulido R; Abriouel H
    Foodborne Pathog Dis; 2013 Feb; 10(2):143-9. PubMed ID: 23259502
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The killing effects of cefathiamidine or ampicillin alone and in combination with gentamicin against enterococci.
    Chen HY; Williams JD
    J Antimicrob Chemother; 1983 Jul; 12(1):19-26. PubMed ID: 6413484
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro evaluation of teicoplanin and other antimicrobials against streptococci group D bacteria.
    Breyer S; Georgopoulos A; Graninger W
    Drugs Exp Clin Res; 1987; 13(8):479-81. PubMed ID: 2962843
    [TBL] [Abstract][Full Text] [Related]  

  • 24. β-Lactams enhance daptomycin activity against vancomycin-resistant Enterococcus faecalis and Enterococcus faecium in in vitro pharmacokinetic/pharmacodynamic models.
    Smith JR; Barber KE; Raut A; Rybak MJ
    Antimicrob Agents Chemother; 2015 May; 59(5):2842-8. PubMed ID: 25753639
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Susceptibility of Enterococcus faecalis to twelve antibiotics, time-kill assays, and high-level aminoglycoside resistance in a university hospital in Argentina.
    Predari SC; Gutiérrez MA; Ribas C; Molinari GS; Santoianni JE
    Rev Argent Microbiol; 1991; 23(2):67-78. PubMed ID: 1815269
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Time-kill and synergism studies of ceftobiprole against Enterococcus faecalis, including beta-lactamase-producing and vancomycin-resistant isolates.
    Arias CA; Singh KV; Panesso D; Murray BE
    Antimicrob Agents Chemother; 2007 Jun; 51(6):2043-7. PubMed ID: 17438057
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In-vitro evaluation of cefpirome (HR 810), teicoplanin and four other antimicrobials against enterococci.
    Chandrasekar PH; Price S; Levine DP
    J Antimicrob Chemother; 1985 Aug; 16(2):179-82. PubMed ID: 2933380
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Multicenter trial of Enterococcus antibiotic susceptibility].
    Sidorenko SV; Rezvan SP; Grudinina SA; Krotova LA; Sterkhova GV
    Antibiot Khimioter; 1998; 43(9):9-18. PubMed ID: 9791681
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synergistic activity of vancomycin and teicoplanin alone and in combination with streptomycin against Enterococcus faecalis strains with various vancomycin susceptibilities.
    Babalola CP; Patel KB; Nightingale CH; Nicolau DP
    Int J Antimicrob Agents; 2004 Apr; 23(4):343-8. PubMed ID: 15081082
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Bactericidal activity of combinations of ticarcillin-clavulanic acid or other beta-lactams (amoxicillin, piperacillin-tazobactam, ticarcillin) with gentamicin against Enterococcus faecalis and E. faecium].
    Leclercq R; Duval J
    Pathol Biol (Paris); 1995 Apr; 43(4):245-52. PubMed ID: 7567109
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro antibacterial activities of eleven antibiotics against S. faecalis.
    Hartzen SH; Frimodt-Möller N; Andreasen JJ
    APMIS; 1988 Jul; 96(7):584-8. PubMed ID: 3136781
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antimicrobial susceptibility of enterococci recovered from healthy cattle, pigs and chickens in nine EU countries (EASSA Study) to critically important antibiotics.
    de Jong A; Simjee S; Garch FE; Moyaert H; Rose M; Youala M; Dry M;
    Vet Microbiol; 2018 Mar; 216():168-175. PubMed ID: 29519512
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In-vitro and in-vivo activity of cefpirome (HR 810) against methicillin-susceptible and -resistant Staphylococcus aureus and Streptococcus faecalis.
    Eng RH; Cherubin CE; Smith SM; Buccini F; Harris R
    J Antimicrob Chemother; 1989 Mar; 23(3):373-81. PubMed ID: 2499565
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High-level resistance to aminoglycosides in enterococci; incidence and alternative active antibiotic combinations in vitro.
    Stefani S; D'Amico G; Mezzatesta ML; Lo Tauro R; Pellegrino MB; Nicoletti G
    Drugs Exp Clin Res; 1990; 16(8):391-5. PubMed ID: 2129028
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Susceptibilities of enterococci to twelve antibiotics.
    Tofte RW; Solliday JA; Crossley KB
    Antimicrob Agents Chemother; 1984 Apr; 25(4):532-3. PubMed ID: 6428309
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Bactericidal activity of daptomycin and vancomycin alone or in combination with tobramycin, netilmicin or ampicillin against enterococcus].
    Duez JM; Péchinot A; Siébor E; Cordin X; Kazmierczak A
    Pathol Biol (Paris); 1989 Apr; 37(4):263-8. PubMed ID: 2543946
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative evaluation of recently developed quinolone compounds--with a note on the frequency of resistant mutants.
    Cullmann W; Stieglitz M; Baars B; Opferkuch W
    Chemotherapy; 1985; 31(1):19-28. PubMed ID: 3156025
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanisms of resistance to imipenem and ampicillin in Enterococcus faecalis.
    Ono S; Muratani T; Matsumoto T
    Antimicrob Agents Chemother; 2005 Jul; 49(7):2954-8. PubMed ID: 15980374
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antimicrobial resistance profiles of Enterococcus faecalis and Enterococcus faecium isolated from artisanal food of animal origin in Argentina.
    Delpech G; Pourcel G; Schell C; De Luca M; Basualdo J; Bernstein J; Grenovero S; Sparo M
    Foodborne Pathog Dis; 2012 Oct; 9(10):939-44. PubMed ID: 22953740
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Consequences of VanE-type resistance on efficacy of glycopeptides in vitro and in experimental endocarditis due to Enterococcus faecalis.
    Lafaurie M; Perichon B; Lefort A; Carbon C; Courvalin P; Fantin B
    Antimicrob Agents Chemother; 2001 Oct; 45(10):2826-30. PubMed ID: 11557476
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.